News | Mammography | February 09, 2023

Implementation of artificial intelligence tool will improve mammography quality and advance breast healthcare

Implementation of artificial intelligence tool will improve mammography quality and advance breast healthcare

February 9, 2023 — Onsite Women’s Health, a leading national provider of breast health services, announces partnership with Volpara Health to adopt Volpara Analytics, an artificial intelligence (AI) software tool that improves mammography quality by assessing every mammogram image for appropriate positioning, compression and radiation dose. This partnership will be implemented in phases, deploying to all Onsite locations nationally this year. 

“Onsite’s overarching goal is to consistently provide the best mammography quality, patient experience and to detect breast cancers at the earliest stage possible. We are committed to cutting edge investments that improve breast health care,” says Brian Marger, chief executive officer, Onsite Women’s Health. “We appreciate Volpara’s commitment to quality as we embark on achieving new levels of breast care with their AI tools.” 

Mammography quality is critical for the early detection of cancer. If a breast is not positioned properly – cancer can be missed. With their advanced image analysis technology and common quality measures applied across the organization, Volpara will provide mammography technologists feedback for each exam and identifiy areas of high performance and areas needing improvement. 

“Onsite’s progressive approach to mammography services challenges the status quo like Volpara’s software. The convenience of having a mammogram done in the primary care or OBGYN office during an annual exam shows an understanding of the busy lives of women,” says Teri Thomas, chief executive officer, Volpara Health. “Women want confidence that they are not sacrificing quality for access, and it is fantastic they receive personalized care with help from our solutions. We are delighted to partner with Onsite to deliver a world class experience and save more families from cancer.” 

“We know mammography quality is critical for the early detection of cancer, our number one priority,” says Susan Holley, MD, PhD, clinical Director of research and development, Onsite Women’s Health.  “Improper positioning can leave tissue out and removes the opportunity to see a cancer. Volpara Analytics software will help us improve and sustain quality through consistent, fair and unbiased assessment of positioning and overall mammography quality.” 

For more information: www.onsitewomenshealth.com 


Related Content

News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | Breast Imaging

March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound ...

Time March 21, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
News | Ultrasound Imaging

Dec. 1, 2024 — At RSNA 2024, Siemens Healthineers introduced Acuson Sequoia 3.51, a major software and hardware update ...

Time December 04, 2024
arrow
News | Mammography

Sept. 30, 2024 — Siemens Healthineers recently announced the Food and Drug Administration’s premarket approval (PMA) for ...

Time September 30, 2024
arrow
News | Breast Imaging

Aug. 28, 2024 — Rezolut, LLC recently debuted its latest offering for patients during their annual mammogram ...

Time August 29, 2024
arrow
Subscribe Now